Johnson & Johnson
JNJ · CIK 0000200406 · Pharmaceutical Preparations
Financial snapshot
Revenue
18,467,000,000
USD · 2014-09-28
Cost of Revenue
8,051,000,000
USD · 2026-06-28
Operating Income
5,827,000,000
USD · 2015-03-29
Net Income
5,534,000,000
USD · 2026-06-28
Total Assets
201,061,000,000
USD · 2026-06-28
Total Liabilities
116,090,000,000
USD · 2026-06-28
Stockholders' Equity
84,971,000,000
USD · 2026-06-28
Cash & Equivalents
20,422,000,000
USD · 2026-06-28
Financial statements
Income Statement — period ending 2026-06-28
| Line item | Value (USD) | Source filing |
|---|---|---|
| Revenue | 49,372,000,000 | 0000200406-26-000153 |
| Cost of Revenue | 16,157,000,000 | 0000200406-26-000153 |
Balance Sheet — period ending 2026-06-28
| Line item | Value (USD) | Source filing |
|---|---|---|
| Accounts Receivable, Current | 19,046,000,000 | 0000200406-26-000153 |
| Inventory | 15,144,000,000 | 0000200406-26-000153 |
| Property, Plant & Equipment, Net | 23,582,000,000 | 0000200406-26-000153 |
| Accounts Payable, Current | 9,223,000,000 | 0000200406-26-000153 |
Cash Flow Statement — period ending 2026-06-28
| Line item | Value (USD) | Source filing |
|---|---|---|
| Capital Expenditures | 2,370,000,000 | 0000200406-26-000153 |
Derived metrics
| Metric | Value | Unit | Period end |
|---|---|---|---|
| capex_intensity | 0.0480 | ratio | 2026-06-28 |
| gross_margin | 0.6727 | ratio | 2026-06-28 |
| inventory_turns_sales_basis | 3.2602 | ratio | 2026-06-28 |
| sales_to_ppe | 2.0936 | ratio | 2026-06-28 |
| working_capital_proxy | 9,823,000,000 | USD | 2026-06-28 |
Leadership (from SEC Forms 3/4/5)
Officers, directors, and ≥10% owners extracted from public SEC ownership filings. Tenure shown is a filing-date range (a proxy, not an official appointment record).
| Name | Title | Roles | First seen | Last seen | Net insider shares |
|---|---|---|---|---|---|
| Woods Eugene A. | Director | Director | 2026-04-27 | 2026-06-11 | 5680 |
| Pinto Daniel E | Director | Director | 2026-04-27 | 2026-06-11 | 9231 |
| Wengel Kathryn E | EVP, Chief TO and Risk Officer | Officer | 2026-06-12 | 2026-06-12 | -50000 |
| HEWSON MARILLYN A | Director | Director | 2026-06-11 | 2026-06-11 | 1074 |
| REED JOHN C | EVP, Innovative Medicine, R&D | Officer | 2026-05-04 | 2026-05-04 | -55010 |
| West Nadja | Director | Director | 2026-04-27 | 2026-04-27 | 4875 |
| WEINBERGER MARK A | Director | Director | 2026-04-27 | 2026-04-27 | 4875 |
| MORIKIS JOHN G | Director | Director | 2026-04-27 | 2026-04-27 | 6160 |
| Broadhurst Vanessa | EVP, Global Corp Affairs | Officer | 2026-07-21 | 2026-07-21 | -23054 |
Stakeholder orientation — people vs. profits (heuristic)
Index: -0.2033 — Balanced. Scale −1 (payout / shareholder-tilted) to +1 (reinvestment / stakeholder-tilted), period ending 2025-12-28.
| Signal | Value | Score | Weight | Basis |
|---|---|---|---|---|
| Reinvestment vs. shareholder payout | -0.0929 | -0.0929 | 0.4 | +1 = all reinvested (capex+R&D); -1 = all paid to shareholders (buybacks+dividends). |
| Capex intensity (local-investment proxy) | 0.0513 | 0.026 | 0.25 | Proxy for building physical/local capacity. NOT a direct outsourcing measure. |
| R&D intensity | 0.0012 | -0.4884 | 0.2 | R&D / revenue — investment in capability and people. |
| Insider alignment (net buy/sell) | -96168.4 | -0.5 | 0.15 | Directional 'skin in the game' signal from insider transactions. |
Methodology & caveats: Heuristic model over public SEC XBRL facts. Signals describe capital allocation during the period, not the character, competence, or 'approval' of any individual. capex_intensity is a proxy for physical/local investment, NOT a direct measure of outsourcing/offshoring (which XBRL does not disclose). Verify against the original filings. Not investment, financial, or HR advice.
Filings (latest 50)
| Form | Filing date | Period | Accession |
|---|---|---|---|
| 10-Q | 2026-07-23 | 2026-06-28 | 0000200406-26-000153 |
| 4 | 2026-07-21 | 2026-07-20 | 0000200406-26-000148 |
| 144 | 2026-07-20 | 0001959173-26-005284 | |
| 8-K | 2026-07-15 | 2026-07-15 | 0000200406-26-000146 |
| 11-K | 2026-06-25 | 2025-12-31 | 0000200406-26-000137 |
| 11-K | 2026-06-25 | 2025-12-31 | 0000200406-26-000135 |
| 4 | 2026-06-12 | 2026-06-11 | 0000200406-26-000127 |
| 4 | 2026-06-11 | 2026-06-09 | 0000200406-26-000125 |
| 4 | 2026-06-11 | 2026-06-09 | 0000200406-26-000123 |
| 4 | 2026-06-11 | 2026-06-09 | 0000200406-26-000121 |
| 144 | 2026-06-11 | 0001959173-26-004553 | |
| SD | 2026-05-27 | 0000200406-26-000119 | |
| 13F-HR | 2026-05-13 | 2026-03-31 | 0000904454-26-000280 |
| 4 | 2026-05-04 | 2026-05-01 | 0000200406-26-000115 |
| SCHEDULE 13G | 2026-05-01 | 0002100119-26-001295 | |
| 8-K | 2026-04-28 | 2026-04-23 | 0000200406-26-000089 |
| 4 | 2026-04-27 | 2026-04-23 | 0000200406-26-000113 |
| 4 | 2026-04-27 | 2026-04-23 | 0000200406-26-000111 |
| 4 | 2026-04-27 | 2026-04-23 | 0000200406-26-000108 |
| 4 | 2026-04-27 | 2026-04-23 | 0000200406-26-000106 |
| 4 | 2026-04-27 | 2026-04-23 | 0000200406-26-000104 |
| 4 | 2026-04-27 | 2026-04-23 | 0000200406-26-000102 |
| 4 | 2026-04-27 | 2026-04-23 | 0000200406-26-000100 |
| 4 | 2026-04-27 | 2026-04-23 | 0000200406-26-000098 |
| 4 | 2026-04-27 | 2026-04-23 | 0000200406-26-000096 |
| 4 | 2026-04-27 | 2026-04-23 | 0000200406-26-000094 |
| 4 | 2026-04-27 | 2026-04-23 | 0000200406-26-000092 |
| 10-Q | 2026-04-22 | 2026-03-29 | 0000200406-26-000087 |
| 8-K | 2026-04-14 | 2026-04-14 | 0000200406-26-000076 |
| SCHEDULE 13G/A | 2026-04-13 | 0000904454-26-000233 | |
| SCHEDULE 13G/A | 2026-03-26 | 0000102909-26-000380 | |
| 13F-HR/A | 2026-03-18 | 2025-12-31 | 0000904454-26-000192 |
| 13F-HR/A | 2026-03-18 | 2025-09-30 | 0000904454-26-000190 |
| 4 | 2026-03-12 | 2025-03-04 | 0000200406-26-000070 |
| 4 | 2026-03-12 | 2026-03-10 | 0000200406-26-000069 |
| 4 | 2026-03-12 | 2026-03-10 | 0000200406-26-000067 |
| ARS | 2026-03-11 | 2025-12-28 | 0001308179-26-000046 |
| DEFA14A | 2026-03-11 | 0000200406-26-000065 | |
| DEF 14A | 2026-03-11 | 2026-03-11 | 0000200406-26-000063 |
| 4 | 2026-03-03 | 2026-02-27 | 0000200406-26-000048 |
| 144 | 2026-02-27 | 0001959173-26-001595 | |
| 4 | 2026-02-23 | 2026-02-20 | 0000200406-26-000046 |
| 144 | 2026-02-20 | 0001959173-26-001256 | |
| 4 | 2026-02-18 | 2026-02-13 | 0000200406-26-000044 |
| 4 | 2026-02-18 | 2026-02-13 | 0000200406-26-000043 |
| 4 | 2026-02-18 | 2026-02-13 | 0000200406-26-000042 |
| 4 | 2026-02-18 | 2026-02-13 | 0000200406-26-000041 |
| 4 | 2026-02-18 | 2026-02-13 | 0000200406-26-000040 |
| 4 | 2026-02-18 | 2026-02-15 | 0000200406-26-000039 |
| 4 | 2026-02-18 | 2026-02-13 | 0000200406-26-000038 |
XBRL facts (showing 100 of 27494)
| Concept | Taxonomy | Period start | Period end | Unit | Value |
|---|---|---|---|---|---|
| EntityCommonStockSharesOutstanding | dei | 2026-07-17 | shares | 2,409,898,597 | |
| AccountsPayableCurrent | us-gaap | 2026-06-28 | USD | 9,223,000,000 | |
| AccountsReceivableNetCurrent | us-gaap | 2026-06-28 | USD | 19,046,000,000 | |
| AccruedIncomeTaxesCurrent | us-gaap | 2026-06-28 | USD | 1,051,000,000 | |
| AccruedIncomeTaxesNoncurrent | us-gaap | 2026-06-28 | USD | 485,000,000 | |
| AccruedLiabilitiesCurrent | us-gaap | 2026-06-28 | USD | 9,464,000,000 | |
| AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | us-gaap | 2026-06-28 | USD | 31,936,000,000 | |
| AccumulatedOtherComprehensiveIncomeLossNetOfTax | us-gaap | 2026-06-28 | USD | -13,951,000,000 | |
| AllowanceForDoubtfulAccountsReceivableCurrent | us-gaap | 2026-06-28 | USD | 171,000,000 | |
| AmortizationOfIntangibleAssets | us-gaap | 2025-12-29 | 2026-06-28 | USD | 2,500,000,000 |
| AmortizationOfIntangibleAssets | us-gaap | 2026-03-30 | 2026-06-28 | USD | 1,200,000,000 |
| AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | us-gaap | 2025-12-29 | 2026-06-28 | shares | 5,100,000 |
| AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | us-gaap | 2026-03-30 | 2026-06-28 | shares | 6,800,000 |
| AociLossCashFlowHedgeCumulativeGainLossAfterTax | us-gaap | 2026-06-28 | USD | -900,000,000 | |
| AssetImpairmentCharges | us-gaap | 2025-12-29 | 2026-06-28 | USD | 220,000,000 |
| Assets | us-gaap | 2026-06-28 | USD | 201,061,000,000 | |
| AssetsCurrent | us-gaap | 2026-06-28 | USD | 59,774,000,000 | |
| AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost | us-gaap | 2026-06-28 | USD | 0 | |
| AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue | us-gaap | 2026-06-28 | USD | 0 | |
| AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost | us-gaap | 2026-06-28 | USD | 5,000,000 | |
| AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue | us-gaap | 2026-06-28 | USD | 5,000,000 | |
| AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate | us-gaap | 2026-06-28 | USD | 5,360,000,000 | |
| AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis | us-gaap | 2026-06-28 | USD | 5,360,000,000 | |
| AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost | us-gaap | 2026-06-28 | USD | 5,355,000,000 | |
| AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue | us-gaap | 2026-06-28 | USD | 5,355,000,000 | |
| AvailableForSaleSecuritiesDebtSecurities | us-gaap | 2026-06-28 | USD | 5,360,000,000 | |
| BusinessCombinationAcquisitionRelatedCosts | us-gaap | 2025-12-29 | 2026-06-28 | USD | 100,000,000 |
| BusinessCombinationContingentConsiderationLiability | us-gaap | 2026-06-28 | USD | 823,000,000 | |
| CashAndCashEquivalentsAtCarryingValue | us-gaap | 2026-06-28 | USD | 20,422,000,000 | |
| CashCashEquivalentsAndShortTermInvestments | us-gaap | 2026-06-28 | USD | 20,758,000,000 | |
| CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | us-gaap | 2026-06-28 | USD | 20,422,000,000 | |
| CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | us-gaap | 2025-12-29 | 2026-06-28 | USD | 713,000,000 |
| CommonStockDividendsPerShareCashPaid | us-gaap | 2025-12-29 | 2026-06-28 | USD/shares | 3 |
| CommonStockDividendsPerShareCashPaid | us-gaap | 2026-03-30 | 2026-06-28 | USD/shares | 1 |
| CommonStockParOrStatedValuePerShare | us-gaap | 2026-06-28 | USD/shares | 1 | |
| CommonStockSharesAuthorized | us-gaap | 2026-06-28 | shares | 4,320,000,000 | |
| CommonStockSharesIssued | us-gaap | 2026-06-28 | shares | 3,119,843,000 | |
| CommonStockValue | us-gaap | 2026-06-28 | USD | 3,120,000,000 | |
| ComprehensiveIncomeNetOfTax | us-gaap | 2025-12-29 | 2026-06-28 | USD | 11,748,000,000 |
| ComprehensiveIncomeNetOfTax | us-gaap | 2026-03-30 | 2026-06-28 | USD | 6,414,000,000 |
| CostOfGoodsAndServicesSold | us-gaap | 2025-12-29 | 2026-06-28 | USD | 16,157,000,000 |
| CostOfGoodsAndServicesSold | us-gaap | 2026-03-30 | 2026-06-28 | USD | 8,051,000,000 |
| DeferredIncomeTaxAssetsNet | us-gaap | 2026-06-28 | USD | 6,728,000,000 | |
| DeferredIncomeTaxExpenseBenefit | us-gaap | 2025-12-29 | 2026-06-28 | USD | -320,000,000 |
| DeferredIncomeTaxLiabilitiesNet | us-gaap | 2026-06-28 | USD | 6,608,000,000 | |
| DepreciationDepletionAndAmortization | us-gaap | 2025-12-29 | 2026-06-28 | USD | 3,963,000,000 |
| DerivativeAssetFairValueGrossLiability | us-gaap | 2026-06-28 | USD | 1,292,000,000 | |
| DerivativeAssets | us-gaap | 2026-06-28 | USD | 92,000,000 | |
| DerivativeFairValueOfDerivativeAsset | us-gaap | 2026-06-28 | USD | 1,384,000,000 | |
| DerivativeFairValueOfDerivativeLiability | us-gaap | 2026-06-28 | USD | 5,538,000,000 | |
| DerivativeInstrumentsInHedgesAssetsAtFairValue | us-gaap | 2026-06-28 | USD | 1,317,000,000 | |
| DerivativeInstrumentsInHedgesLiabilitiesAtFairValue | us-gaap | 2026-06-28 | USD | 5,471,000,000 | |
| DerivativeLiabilities | us-gaap | 2026-06-28 | USD | 117,000,000 | |
| DerivativeLiabilityFairValueGrossAsset | us-gaap | 2026-06-28 | USD | 5,421,000,000 | |
| DividendsCommonStockCash | us-gaap | 2025-12-29 | 2026-06-28 | USD | 6,358,000,000 |
| DividendsCommonStockCash | us-gaap | 2026-03-30 | 2026-06-28 | USD | 3,227,000,000 |
| EarningsPerShareBasic | us-gaap | 2025-12-29 | 2026-06-28 | USD/shares | 4 |
| EarningsPerShareBasic | us-gaap | 2026-03-30 | 2026-06-28 | USD/shares | 2 |
| EarningsPerShareDiluted | us-gaap | 2025-12-29 | 2026-06-28 | USD/shares | 4 |
| EarningsPerShareDiluted | us-gaap | 2026-03-30 | 2026-06-28 | USD/shares | 2 |
| EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | us-gaap | 2025-12-29 | 2026-06-28 | USD | -20,000,000 |
| EffectiveIncomeTaxRateContinuingOperations | us-gaap | 2025-12-29 | 2026-06-28 | pure | 0 |
| EmployeeRelatedLiabilitiesCurrent | us-gaap | 2026-06-28 | USD | 3,475,000,000 | |
| EmployeeRelatedLiabilitiesCurrentAndNoncurrent | us-gaap | 2026-06-28 | USD | 6,657,000,000 | |
| EquitySecuritiesFvNi | us-gaap | 2026-06-28 | USD | 803,000,000 | |
| FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases | us-gaap | 2025-12-29 | 2026-06-28 | USD | 64,000,000 |
| FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements | us-gaap | 2025-12-29 | 2026-06-28 | USD | 0 |
| FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue | us-gaap | 2026-06-28 | USD | 823,000,000 | |
| FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths | us-gaap | 2026-06-28 | USD | 4,400,000,000 | |
| FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear | us-gaap | 2026-06-28 | USD | 5,100,000,000 | |
| FiniteLivedIntangibleAssetsAmortizationExpenseYearFour | us-gaap | 2026-06-28 | USD | 3,500,000,000 | |
| FiniteLivedIntangibleAssetsAmortizationExpenseYearThree | us-gaap | 2026-06-28 | USD | 3,600,000,000 | |
| FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo | us-gaap | 2026-06-28 | USD | 3,700,000,000 | |
| GainLossOnSalesOfAssetsAndAssetImpairmentCharges | us-gaap | 2025-12-29 | 2026-06-28 | USD | 43,000,000 |
| Goodwill | us-gaap | 2026-06-28 | USD | 48,479,000,000 | |
| GoodwillAcquiredDuringPeriod | us-gaap | 2025-12-29 | 2026-06-28 | USD | 3,000,000 |
| GoodwillOtherIncreaseDecrease | us-gaap | 2025-12-29 | 2026-06-28 | USD | -296,000,000 |
| GoodwillWrittenOffRelatedToSaleOfBusinessUnit | us-gaap | 2025-12-29 | 2026-06-28 | USD | 0 |
| GrossProfit | us-gaap | 2025-12-29 | 2026-06-28 | USD | 33,215,000,000 |
| GrossProfit | us-gaap | 2026-03-30 | 2026-06-28 | USD | 17,259,000,000 |
| IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | us-gaap | 2025-12-29 | 2026-06-28 | USD | 12,737,000,000 |
| IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | us-gaap | 2026-03-30 | 2026-06-28 | USD | 6,747,000,000 |
| IncomeTaxExpenseBenefit | us-gaap | 2025-12-29 | 2026-06-28 | USD | 1,968,000,000 |
| IncomeTaxExpenseBenefit | us-gaap | 2026-03-30 | 2026-06-28 | USD | 1,213,000,000 |
| IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | us-gaap | 2025-12-29 | 2026-06-28 | USD | -956,000,000 |
| IncreaseDecreaseInAccountsReceivable | us-gaap | 2025-12-29 | 2026-06-28 | USD | 1,947,000,000 |
| IncreaseDecreaseInInventories | us-gaap | 2025-12-29 | 2026-06-28 | USD | 1,002,000,000 |
| IncreaseDecreaseInOtherOperatingAssets | us-gaap | 2025-12-29 | 2026-06-28 | USD | -1,299,000,000 |
| IncreaseDecreaseInOtherOperatingLiabilities | us-gaap | 2025-12-29 | 2026-06-28 | USD | -1,601,000,000 |
| IncrementalCommonSharesAttributableToShareBasedPaymentArrangements | us-gaap | 2025-12-29 | 2026-06-28 | shares | 96,700,000 |
| IncrementalCommonSharesAttributableToShareBasedPaymentArrangements | us-gaap | 2026-03-30 | 2026-06-28 | shares | 92,900,000 |
| IntangibleAssetsNetExcludingGoodwill | us-gaap | 2026-06-28 | USD | 48,229,000,000 | |
| InterestExpenseNonoperating | us-gaap | 2025-12-29 | 2026-06-28 | USD | 553,000,000 |
| InterestExpenseNonoperating | us-gaap | 2026-03-30 | 2026-06-28 | USD | 281,000,000 |
| InventoryFinishedGoodsNetOfReserves | us-gaap | 2026-06-28 | USD | 8,405,000,000 | |
| InventoryNet | us-gaap | 2026-06-28 | USD | 15,144,000,000 | |
| InventoryRawMaterialsAndSuppliesNetOfReserves | us-gaap | 2026-06-28 | USD | 2,515,000,000 | |
| InventoryWorkInProcessNetOfReserves | us-gaap | 2026-06-28 | USD | 4,224,000,000 | |
| InvestmentIncomeInterest | us-gaap | 2025-12-29 | 2026-06-28 | USD | 448,000,000 |
| InvestmentIncomeInterest | us-gaap | 2026-03-30 | 2026-06-28 | USD | 219,000,000 |
Download data
Full profile (JSON)XBRL facts (CSV)Derived metrics (CSV)Statements (CSV)Filings (CSV)